Selskabets formål er at udvikle biotekbaserede kosttilskud, der forbedrer menneskers sundhed og relateret forretningsaktiviteter.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -1.2 mio. | -2.1 mio. | 2.1 mio. | -1 mio. | 4 | |
CVR: 42551759
Compared to 997 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Ib Christensen joined the board
Mathias Brink Lorenz joined the board
Mikkel Holstener Precht joined the board
Alasdair Robert Tsin Voon Thong joined the board
Manigoff Invest ApS registered with 5% ownership
Iconsult ApS registered with 10% ownership
Delphinus Venture Capital K/S registered with 5% ownership
registered with 15% ownership
registered with 15% ownership
Mads Emil Mikkelsen left as director
Companies in the same industry and area
companydata.dk